Flow cytometric analysis of the calcitonin receptor-like receptor domains responsible for cell-surface translocation of receptor activity-modifying proteins

Biochemical and Biophysical Research Communications

Volumn 384, Issue 2, 2009, Pages 249-254

  Kuwasako, Kenji ^a   Kitamura, Kazuo ^b   Nagata, Sayaka ^b   Kato, Johji ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Calcitonin receptor like receptor; Chimeric receptor; Flow cytometry; Receptor activity modifying proteins; Translocation

Indexed keywords

CALCITONIN RECEPTOR LIKE RECEPTOR; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; RECEPTOR ACTIVITY MODIFYING PROTEIN 2; RECEPTOR ACTIVITY MODIFYING PROTEIN 3; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL MEMBRANE; CELL SURFACE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN INTERACTION;

CELL LINE; CELL MEMBRANE; FLOW CYTOMETRY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RECEPTORS, CALCITONIN; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE, TYPE II; RECOMBINANT FUSION PROTEINS;

EID: 65549109041     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.04.097     Document Type: Article

References (23)

1. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., Solari R., Lee M.G., and Foord S.M. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393 (1998) 333-339
2. Hay D.L., Poyner D.R., and Sexton P.M. GPCR modulation by RAMPs. Pharmacol. Ther. 109 (2006) 173-197
3. Bouschet T., Martin S., and Henley J.M. Regulation of calcium-sensing-receptor trafficking and cell-surface expression by GPCRs and RAMPs. Trends Pharmacol. Sci. 29 (2008) 633-639
4. Sexton P.M., Sexton D.R., Simms J., Christopoulos A., and Hay D.L. Modulating receptor function through RAMPs: can they represent drug targets in themselves?. Drug Discov. Today 14 (2009) 413-419
5. Gibbons C., Dackor R., Dunworth W., Fritz-Six K., and Caron K.M. Receptor activity-modifying proteins: RAMPing up adrenomedullin signaling. Mol. Endocrinol. 21 (2007) 783-796
6. Kuwasako K., Kitamura K., Nagata S., and Kato J. Functions of the extracellular histidine residues of receptor activity-modifying proteins vary within adrenomedullin receptors. Biochem. Biophys. Res. Commun. 377 (2008) 109-113
7. Kuwasako K., Kitamura K., Nagoshi Y., Cao Y.N., and Eto T. Identification of the human receptor activity-modifying protein 1 domains responsible for agonist binding specificity. J. Biol. Chem. 278 (2003) 22623-22630
8. Kuwasako K., Shimekake Y., Masuda M., Nakahara K., Yoshida T., Kitaura M., Kitamura K., Eto T., and Sakata T. Visualization of the calcitonin receptor-like receptor and its receptor activity-modifying proteins during internalization and recycling. J. Biol. Chem. 275 (2000) 29602-29609
9. Kuwasako K., Cao Y.N., Chu C.P., Iwatsubo S., Eto T., and Kitamura K. Functions of the cytoplasmic tails of the human receptor activity-modifying protein components of calcitonin gene-related peptide and adrenomedullin receptors. J. Biol. Chem. 281 (2006) 7205-7213
10. Christopoulos A., Christopoulos G., Morfis M., Udawela M., Laburthe M., Couvineau A., Kuwasako K., Tilakarayne N., and Sexton P.M. Novel receptor partners and function of receptor activity-modifying proteins. J. Biol. Chem. 278 (2003) 3293-3297
11. Kuwasako K., Kitamura K., Uemura T., Nagoshi Y., Kato J., and Eto T. The function of extracellular cysteines in the human adrenomedullin receptor. Hypertens. Res. 26 (2003) S25-S31
12. Flahaut M., Rossier B.C., and Firsov D. Respective roles of calcitonin receptor-like receptor (CRLR) and receptor activity-modifying proteins (RAMP) in cell surface expression of CRLR/RAMP heterodimeric receptors. J. Biol. Chem. 277 (2002) 14731-14737
13. 69 of the calcitonin-like receptor is required for its functional expression together with receptor-activity-modifying proteins 1 and -2. Biochem. Biophys. Res. Commun. 319 (2004) 1203-1209
14. Tilakaratne N., Christopoulos G., Zumpe E.T., Foord S.M., and Sexton P.M. Amilyn receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment. J. Pharmacol. Exp. Ther. 294 (2000) 61-72
15. Koller D., Ittner L.M., Muff R., Husmann K., Fischer J.A., and Born W. Selective inactivation of adrenomedullin over calcitonin gene-related peptide receptor function by the deletion of amino acids 14-20 of mouse calcitonin-like receptor. J. Biol. Chem. 279 (2004) 20387-20391
16. Kuwasako K., Kitamura K., Nagoshi Y., and Eto T. Novel calcitonin-(8-32)-sensitive adrenomedullin receptors derived from co-expression of calcitonin receptor with receptor activity-modifying proteins. Biochem. Biophys. Res. Commun. 301 (2003) 460-464
17. Morfis M., Tilakaratne N., Furness S.G., Christopoulos G., Werry T.D., Christopoulos A., and Sexton P.M. Receptor activity-modifying proteins differentially modulates the G protein-coupling efficiency of amylin receptors. Endocrinology 149 (2008) 5423-5431
18. Kuwasako K., Cao Y.N., Nagoshi Y., Tsuruda T., Kitamura K., and Eto T. Characterization of the human calcitonin gene-related peptide receptor subtypes associated with receptor activity-modifying proteins. Mol. Pharmacol. 65 (2004) 207-213
19. Fitzsimmons T.J., Zhao X., and Wank S.A. The extracellular domain of receptor activity-modifying protein 1 is sufficient for calcitonin receptor-like receptor function. J. Biol. Chem. 278 (2003) 14313-14320
20. Ittner L.M., Koller D., Muff R., Fischer J.A., and Born W. The N-terminal extracellular domain 23-60 of the calcitonin receptor-like receptor in chimeras with the parathyroid hormone receptor mediates association with receptor activity-modifying protein 1. Biochemistry 44 (2005) 5749-5754
21. Salvatore C.A., Mallee J.J., Bell I.M., Zartman C.B., Williams T.M., Koblan K.S., and Kane S.A. Identification and pharmacological characterization of domains involved in binding of CGRP receptor antagonists to the calcitonin-like receptor. Biochemistry 45 (2006) 1881-1887
22. Lee J., Gomez-Ramirez J., Johnson T.H., Visanji N., and Brotchie J.M. Receptor-activity modifying protein 1 expression is increased in the striatum following repeated L-DOPA administration in a 6-hydroxydopamine lesions rat model of Parkinson's disease. Synapse 62 (2008) 310-313
23. Cooray S.N., Chan L., Webb T.R., Metherell L., and Clark A.J. Accessory proteins are vital for the functional expression of certain G protein-coupled receptors. Mol. Cell. Endocrinol. 300 (2009) 17-24